Life Sciences Tools and Services
Company Overview of Biomodels, LLC
Biomodels, LLC is a preclinical contract research organization that develops and conducts predictive translational studies for biotechnology and pharmaceutical companies. The company specializes in testing and evaluating drugs primarily in the areas of cancer, toxicology, pharmacology, cancer supportive care, psychiatric disorders, radiation therapy, and inflammatory diseases, as well as mucosal injury, obesity, diabetes, and antibody production and testing. It also engages in custom study design, development, and optimization services; and non-GLP studies that optimize dose, as well as schedule and define mechanism of action. The company was founded in 1997 and is based in Watertown, Massac...
313 Pleasant Street
Watertown, MA 02472
Founded in 1997
Key Executives for Biomodels, LLC
Founder and Managing Partner
Chief Medical Officer and Chief Medical Consultant
Compensation as of Fiscal Year 2015.
Biomodels, LLC Key Developments
Biomodels, LLC Announces the Signing of a Joint Services Agreement with Numira Inc
Jan 7 14
Biomodels, LLC announced the signing of a joint services agreement with Numira Inc. Under the terms of the agreement, Biomodels and Numira will facilitate access to each other's services to assist clients with expediting drug, biological, and device conversion from concept to clinic. Additionally, the collaboration will focus on joint optimization of modeling outcomes to maximize the predictive value and efficiency of the pre-clinical process. The alliance brings together Biomodels' 17 years of experience in the development, biological definition, and validation of pre-clinical models with Numira's unique 3D high-resolution, quantitative microCT imaging and specialized histology services. Clients will now have the opportunity to more robustly visualize and quantify morphological signals that are associated with efficacy end-points.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries